Taclink(SH:688205) Shang Hai Zheng Quan Bao·2025-11-11 19:40Investment Overview - The company plans to invest 300 million RMB in its wholly-owned subsidiary, ACT TECHNOLOGY SG PTE. LTD. (referred to as "Decoli Singapore") to enhance overseas R&D, market system construction, and production capacity expansion [2][4] - This investment does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations [6][5] Company Structure and Financials - Decoli Singapore was established on May 27, 2024, with a registered capital of 3 million USD and a total investment of 8 million USD [3][8] - The company is fully owned by Wuxi Decoli Optoelectronic Technology Co., Ltd., which holds 100% of the shares [9] Strategic Impact - The investment is aligned with the company's long-term strategy and market outlook, aimed at strengthening its international R&D capabilities and enhancing its competitive position in the global market [10] - The funding will come from the company's own or self-raised funds, ensuring that it will not significantly impact the company's financial status or normal operations [10] Decision-Making Process - The investment proposal was approved unanimously by the company's board of directors during the 17th meeting of the second board session held on November 11, 2025 [5][20] - The decision does not require shareholder approval as it falls within the board's authority [21] Future Plans - The company is also planning to issue S-shares and list on the Singapore Exchange to enhance its overseas financing capabilities and expand its international capital platform [13][18] - The specific details of the S-share issuance are still under discussion with relevant intermediaries [18]